Home > Calculus Capital and Amadeus Capital Partners Ltd. acquire Axol Bioscience Ltd.
Transaction · Life Science

Calculus Capital and Amadeus Capital Partners Ltd. acquire Axol Bioscience Ltd.

Calculus Capital and Amadeus Capital Partners Ltd. acquired Axol Bioscience Ltd., a life science company in United Kingdom.

Deal at a glance

TargetAxol Bioscience Ltd. Buyers Calculus Capital
Amadeus Capital Partners Ltd.
SectorLife Science LocationUnited Kingdom ValueNot disclosed

Target company

Axol Bioscience Ltd.
United Kingdom
Life Sciencesector
2013founded
Activestatus
View the company profile →

Buyers (2)

Company · 22 deals on record
Private equity firm · 61 deals on record
22deals, all time
8in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Destiny Pharma plcSame lead buyer · Mar 2022
Theramex HQ UK Ltd.Same sector and country · Nov 2026
Drug Development SolutionsSame sector and country · May 2022
Aptus Clinical Ltd.Same sector and country · May 2022

Questions about this deal

Who acquired Axol Bioscience Ltd.?Calculus Capital and Amadeus Capital Partners Ltd. acquired Axol Bioscience Ltd..

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).